IBO.AMEXImpact Biomedical INC
8-K: Impact Biomedical Appoints Chan Heng Fai Ambrose to Board of Directors
Sentiment:
Current Report
Impact Biomedical Inc. announces the appointment of Mr. Chan Heng Fai Ambrose, a seasoned financial expert, to its Board of Directors, effective March 11, 2025.
Summary
- Impact Biomedical Inc. has appointed Mr. Chan Heng Fai Ambrose as a Director, effective March 11, 2025.
- Mr. Chan brings over 45 years of experience in the financial and equity investment industry.
- He has a strong background in banking and finance and has restructured numerous companies across various industries and countries.
- Mr. Chan currently holds or has held director and chairman positions in several publicly listed companies, including Alset International Limited, Hapi Metaverse Inc., DSS, Inc., LiquidValue Development Inc., Alset Inc., Sharing Services Global Corporation, HWH International Inc., and Value Exchange International, Inc.
Sentiment
Score: 7
Explanation: The announcement is positive due to the addition of an experienced director, but it's a routine corporate event, hence the moderate sentiment score.
Positives
- The appointment of Mr. Chan Heng Fai Ambrose brings significant financial and restructuring expertise to Impact Biomedical's Board of Directors.
- Mr. Chan's extensive experience across various industries and public companies could provide valuable insights and guidance to the company.
Industry Context
The appointment of experienced financial professionals to boards of directors is a common practice in the biomedical industry to provide strategic guidance and oversight.
Comparison to Industry Standards
- Comparing Impact Biomedical's board composition to similar companies in the biomedical sector reveals a trend of including individuals with diverse backgrounds in finance, healthcare, and technology.
- For example, companies like Moderna and BioNTech have board members with extensive experience in venture capital, pharmaceutical development, and regulatory affairs.
- Mr. Chan's experience aligns with this trend, bringing financial expertise to the board.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | Chan Heng Fai Ambrose | March 11, 2025 | Appointment |
Stakeholder Impact
- Shareholders may view the appointment positively, anticipating improved strategic decision-making and corporate governance.
- Employees may benefit from Mr. Chan's expertise in restructuring and financial management.
Key Dates
| Date | Description |
|---|---|
| September 1992 | Mr. Chan served as director of Heng Fai Enterprises Limited |
| 1995 to 2015 | Mr. Chan served as Managing Chairman of Heng Fai Enterprises Limited |
| 1997 to 2002 | Mr. Chan served as the Executive Chairman of China Gas Holdings Limited |
| March 2003 to September 2013 | Mr. Chan was formerly the Managing Director of SingHaiyi Group Ltd. |
| May 2013 | Mr. Chan has served as director of Alset International Limited |
| July 2013 until June 2021 | Mr. Chan served as director of Holista CollTech Ltd. |
| December 2013 to July 2015 | He also served as director of Global Medical REIT Inc. |
| April 2014 | Mr. Chan has served as its Chief Executive Office of Alset International Limited |
| June 2014 to February 2019 | Mr. Chan served as director of RSI International Systems, Inc. |
| June 2017 | Mr. Chan has served as its Chairman of the Board of Alset International Limited |
| January 2017 | Mr. Chan has served as director of DSS, Inc. and LiquidValue Development Inc. |
| December 2017 | Mr. Chan has served as its Chairman of the Board of LiquidValue Development Inc. |
| March 2018 | Mr. Chan is the founder of Alset Inc. |
| June 2018 until April 2022 | Mr. Chan served as director of OptimumBank Holdings, Inc. |
| March 2019 | Mr. Chan has served as its Chairman of the Board of DSS, Inc. |
| April 2020 | Mr. Chan has served as director of Sharing Services Global Corporation |
| July 2021 | Mr. Chan has served as its Chairman of the Board of Sharing Services Global Corporation and Hapi Metaverse Inc. |
| October 2014 | Mr. Chan has served as director of Hapi Metaverse Inc. |
| October 2021 | Mr. Chan has served as Chairman of the Board and Chief Executive Officer of HWH International Inc. |
| December 2021 | Mr. Chan has served as director of Value Exchange International, Inc. |
| January 2024 | Mr. Chan served as Chief Executive Officer of HWH International Inc. |
| March 11, 2025 | Mr. Chan Heng Fai Ambrose appointed as Director of Impact Biomedical Inc. |
| March 13, 2025 | Date of report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.